Shilin Xu
Nanjing University of Chinese Medicine(CN)Chinese Academy of Sciences(CN)Wuhan University(CN)Affiliated Hospital of Southwest Medical University(CN)Shanghai Institute of Materia Medica(CN)Guangzhou First People's Hospital(CN)Renmin Hospital of Wuhan University(CN)Center for Disease Control(TW)University of Chinese Academy of Sciences(CN)Henan Agricultural University(CN)South China University of Technology(CN)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Protein Degradation and Inhibitors, Lymphoma Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Tryptophan and brain disorders
Most-Cited Works
- → Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment(2020)192 cited
- → Design, Synthesis, and Biological Evaluation of Novel Conformationally Constrained Inhibitors Targeting Epidermal Growth Factor Receptor Threonine790 → Methionine790 Mutant(2012)83 cited
- → 1-Phenyl-4-benzoyl-1H-1,2,3-triazoles as Orally Bioavailable Transcriptional Function Suppressors of Estrogen-Related Receptor α(2013)69 cited
- → Design of the First‐in‐Class, Highly Potent Irreversible Inhibitor Targeting the Menin‐MLL Protein–Protein Interaction(2017)61 cited
- → Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status(2023)57 cited
- → Discovery of a PROTAC degrader for METTL3-METTL14 complex(2024)54 cited